Family Office Of America (FOFA) Net Cash Flow (2021 - 2026)
Family Office Of America (FOFA) reported Net Cash Flow of $187422.0 for Q1 2026, down 66.02% on a YoY basis from $551636.0 in Q1 2025, and up 268.54% sequentially from -$111200.0 in Q4 2025.
Family Office Of America (FOFA) Net Cash Flow (2021 - 2026) Analysis & Trends
Family Office Of America (FOFA) has 6 years of Net Cash Flow data on file, last reported at $187422.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 66.02% year-over-year to $187422.0; the trailing twelve-month figure through Mar 2026 stood at $338598.0 (down 28.66% YoY), and the FY2025 full-year result was $142212.0, up 1174.87% from the prior year.
- Net Cash Flow rose to $187422.0 in Q1 2026, from -$111200.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $551636.0 in Q1 2025 to a low of -$172198.0 in Q2 2022.
- A 5-year average of $15672.6 and a median of -$23296.0 in 2023 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow slumped 424.04% in 2024 and jumped 1591.05% in 2025, its largest moves.
- Tracing FOFA's Net Cash Flow over 5 years: stood at -$102094.0 in 2022, then surged by 92.16% to -$8002.0 in 2023, then tumbled by 313.87% to -$33118.0 in 2024, then slumped by 235.77% to -$111200.0 in 2025, then surged by 268.54% to $187422.0 in 2026.
- Business Quant data shows FOFA's Net Cash Flow at $187422.0 in Q1 2026, -$111200.0 in Q4 2025, and $242325.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | 187,422.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,422.00 |
| Mar 31, 2026 | 187,422.00 |
| Dec 31, 2025 | -111,200.00 |
| Dec 31, 2025 | -111,200.00 |
| Sep 30, 2025 | 242,325.00 |
| Sep 30, 2025 | 242,325.00 |
| Jun 30, 2025 | 20,051.00 |
| Jun 30, 2025 | 20,051.00 |
| Mar 31, 2025 | 551,636.00 |
| Mar 31, 2025 | 551,636.00 |
| Dec 31, 2024 | -33,118.00 |
| Dec 31, 2024 | -33,118.00 |
| Sep 30, 2024 | -16,252.00 |
| Sep 30, 2024 | -16,252.00 |
| Jun 30, 2024 | -27,615.00 |
| Jun 30, 2024 | -27,615.00 |
| Mar 31, 2024 | 88,140.00 |
| Mar 31, 2024 | 88,140.00 |
| Dec 31, 2023 | -8,002.00 |
| Dec 31, 2023 | -8,002.00 |